The use of Pimavanserin in the treatment of Parkinson’s Disease: a consideration of its effects on sleep

Defining Extreme Phenotypes of OSA across International Sleep Centers

Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma

Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial

Exercise for “Sleep Rehabilitation” in Parkinson’s Disease

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support